Clinical Trials Directory

Trials / Completed

CompletedNCT04973553

Dose Escalation Upper Limb Rehabilitation in Stroke

Finding the Optimal Session Length of Upper Limb Rehabilitation of People With Moderate to Severe Upper Limb Sensorimotor Impairments After Acute Stroke: A Dose Escalation Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Hasselt University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A phase 1, single-ascending dose clinical trial will be conducted. This study will be designed to test increasing doses of multimodal exercise in successive cohorts of six participants (cumulative 3 + 3 design)\[22\] (Figure 1). Maximum dose is reached when two or more participants experience DLT. DLT, dose-limiting tolerance. The 'dose' will be defined as the ability to reach a fixed maximal level of exercise (type, duration (including session length) in the first two weeks post-stroke without experiencing dose-limiting tolerance (DLT). DLT thresholds will be based on failure to completeshould be less than 80% of prescribed 3-day rehabilitation dose due to pain, rate of perceived exertion, fatigue, or effort required. Rehabilitation and measurement sessions will be held at either at the Stroke or Geriatric Units at Campus Sint-Jan, Genk or at the rehabilitation unit at Sint-Barbara, Lanaken and Cliniques Saint-Luc with medical services on site. All participants will be monitored for fatigue and pain pre, during and at post-intervention daily. The researchers (PI of project \[Dr Peter Hallet, ZOL\] Postdoctoral Researcher \[Dr Lisa Tedesco Triccas, UHasselt\] and PhD/Masters Students \[UHasselt) will conduct the clinical tests and will conduct the rehabilitation program.

Conditions

Interventions

TypeNameDescription
OTHERupper limb rehabilitationthe intervention consisting of two components: a) Upper limb training protocol; b) Technology-assist training.

Timeline

Start date
2021-08-20
Primary completion
2024-05-27
Completion
2024-05-27
First posted
2021-07-22
Last updated
2024-05-29

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT04973553. Inclusion in this directory is not an endorsement.